Summit Accumulated Other Comprehensive Income from 2010 to 2024

SMMT Stock  USD 19.00  0.58  3.15%   
Summit Therapeutics Accumulated Other Comprehensive Income yearly trend continues to be comparatively stable with very little volatility. Accumulated Other Comprehensive Income is likely to outpace its year average in 2024. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2013-06-30
Previous Quarter
-2.5 M
Current Value
-2.3 M
Quarterly Volatility
15.4 M
 
Yuan Drop
 
Covid
Check Summit Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Summit Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 17.3 M or Selling General Administrative of 31.8 M, as well as many indicators such as Price To Sales Ratio of 1.3 K, Dividend Yield of 0.0 or PTB Ratio of 19.78. Summit financial statements analysis is a perfect complement when working with Summit Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Summit Therapeutics Correlation against competitors.

Latest Summit Therapeutics' Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of Summit Therapeutics PLC over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Summit Therapeutics' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Summit Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Very volatile
   Accumulated Other Comprehensive Income   
       Timeline  

Summit Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean8,021,932
Geometric Mean3,553,855
Coefficient Of Variation191.10
Mean Deviation13,879,900
Median(1,893,000)
Standard Deviation15,329,628
Sample Variance235T
Range36.4M
R-Value(0.01)
Mean Square Error253.1T
R-Squared0.000037
Significance0.98
Slope(20,888)
Total Sum of Squares3290T

Summit Accumulated Other Comprehensive Income History

2024-2.3 M
2023-2.4 M
2022-1.9 M
2021-2.2 M
2020-3.8 M
201928.3 M
201830.3 M

About Summit Therapeutics Financial Statements

Summit Therapeutics shareholders use historical fundamental indicators, such as Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although Summit Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Summit Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Summit Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-2.4 M-2.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Summit Stock Analysis

When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.